712 filings
EFFECT
TENX
Tenax Therapeutics Inc
15 Apr 24
Notice of effectiveness
12:15am
EFFECT
TENX
Tenax Therapeutics Inc
15 Apr 24
Notice of effectiveness
12:15am
POS AM
TENX
Tenax Therapeutics Inc
11 Apr 24
Prospectus update (post-effective amendment)
4:59pm
POS AM
TENX
Tenax Therapeutics Inc
11 Apr 24
Prospectus update (post-effective amendment)
4:56pm
10-K
2023 FY
TENX
Tenax Therapeutics Inc
Annual report
28 Mar 24
2:02pm
8-K
gfzig
28 Mar 24
Tenax Therapeutics Provides Business and Clinical Development Updates with Full Year 2023 Financial Results
8:45am
424B3
voqkicvy611wuat7s1b
26 Feb 24
Prospectus supplement
4:31pm
424B3
7j53hg3tu36lqkebxa8
26 Feb 24
Prospectus supplement
4:31pm
8-K
owv6m2udr ns6l27
23 Feb 24
Other Events
4:30pm
424B3
n031j3ec4hg0iz
21 Feb 24
Prospectus supplement
4:32pm
424B3
83n2bh
21 Feb 24
Prospectus supplement
4:30pm
SC 13G
9qj2lkib0jrt 21t9pi
20 Feb 24
TENAX THERAPEUTICS / S.H.N. Financial Investments ownership change
4:01pm
8-K
xsut18ltjhzmrlwnm
20 Feb 24
Tenax Therapeutics Announces Global License Amendment that Significantly Expands Rights to Levosimendan
8:33am
SC 13G
x0wh8uaaljhlx8
16 Feb 24
TENAX THERAPEUTICS / CVI Investments ownership change
11:28am
SC 13G
1n99u3akr67eie87t4cy
15 Feb 24
TENAX THERAPEUTICS / Lind Global Fund II ownership change
7:36pm
SC 13G/A
dwurj s4x
14 Feb 24
TENAX THERAPEUTICS / ARMISTICE CAPITAL ownership change
2:58pm
424B3
mrdc5b7
13 Feb 24
Prospectus supplement
4:32pm
8-K
t30 kql8orr
12 Feb 24
Tenax Therapeutics Announces Pricing of Approximately $9 Million Public Offering
4:46pm
424B4
q2x14xcs
9 Feb 24
Prospectus supplement with pricing info
5:00pm
424B3
aztsc0n6dt7vacvs
8 Feb 24
Prospectus supplement
4:51pm